Theriva Biologics files prospectus for up to $4 million at-the-market offering
PositiveFinancial Markets

Theriva Biologics has filed a prospectus for an at-the-market offering that could raise up to $4 million. This move is significant as it allows the company to access funds directly from the market, potentially accelerating its growth and development in the biotechnology sector. Investors may see this as a positive sign of the company's confidence in its future prospects.
— Curated by the World Pulse Now AI Editorial System









